Advanced Biomed ADVB
NASDAQ ADVB
$9.50 +0.26 (+2.81%)
As of: Aug 27, 2026 · 3:59 PM EDT

Advanced Biomed (ADVB) Liabilities from Discontinued Operations (2025)

Advanced Biomed (ADVB) posted Liabilities from Discontinued Operations of 8183094.0 for Q2 2025.

Advanced Biomed (ADVB) Liabilities from Discontinued Operations (2025) Analysis & Trends

Advanced Biomed has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 8183094.0 in Q2 2025.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 8183094.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 8183094.0 (changed N/A YoY) and the FY2025 annual result came in at 8183094.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations steadied at 8183094.0 in Q2 2025 per ADVB's latest filing.
  • Over five years, Liabilities from Discontinued Operations peaked at 8183094.0 in Q2 2025 and troughed at 8183094.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Advanced Biomed 12.28 Mn 12.28 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 8.18 Mn
Jun 30, 2025 8.18 Mn